Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease.
Hui-Hui LiuYe-Xuan CaoJing-Lu JinHui-Wen ZhangQi HuaYan-Fang LiYuan-Lin GuoCheng-Gang ZhuNa-Qiong WuYing GaoRui-Xia XuLi-Feng HongJian-Jun LiPublished in: Heart (British Cardiac Society) (2020)
Circulating Lp(a) concentration was indeed a useful predictor for the risk of RCVEs in real-world treated patients with CAD, providing additional information concerning the future clinical application of Lp(a).